A Randomized Controlled Trial Investigating the Feasibility of a Low-Intensity Psychological Intervention for Fear of Memory Loss and Quality of Life in Older Adults: Protocol for the Reducing Fear and Avoidance of Memory Loss (REFRAME) Study

Patricia O'Loughlin, Pavithra Pavithra, John Regan, Marc Bennett, Rachel Knight, Bert Lenaert, Melissa Marquez, Michelle Taddeo, James Griffith, Rita Shapiro, Francesca Farina, Patricia O'Loughlin, Pavithra Pavithra, John Regan, Marc Bennett, Rachel Knight, Bert Lenaert, Melissa Marquez, Michelle Taddeo, James Griffith, Rita Shapiro, Francesca Farina

Abstract

Background: Dementia is the most feared disease associated with aging. Prolonged fears about memory loss and dementia can have harmful consequences even in the absence of cognitive decline. Fear of dementia is associated with poorer health outcomes and psychological well-being and increased memory failures in older adults.

Objective: We will conduct a randomized controlled trial to determine the feasibility of a tailored, web-based mindfulness program to reduce fear of memory loss and increase quality of life in older adults experiencing heightened fear.

Methods: Eighty participants will be recruited and divided into 2 groups (40 in each group). One group will receive psychoeducation plus mindfulness training. A second group will receive psychoeducation, mindfulness training, and additional modules targeting maladaptive behavioral avoidance (ie, social and cognitive withdrawal).

Results: Our recent etiological model posits that maladaptive behavioral avoidance strategies critically underlie psychosocial dysfunction associated with fear of memory loss. Thus, we predict better outcomes in the second group, including reduced fear of memory loss (primary outcome), Alzheimer disease, anxiety, and subjective memory failures, and increased quality of life (secondary outcomes). Outcome measures will be applied at 5 time points (before, baseline, interim, and after the intervention, and at 3-month follow-up). Data will be analyzed using mixed models and correlations.

Conclusions: Results from this study will contribute to the current literature on dementia-related fear and improve our understanding of how to effectively address and reduce these fears.

Trial registration: ClinicalTrials.gov NCT04821960; https://ichgcp.net/clinical-trials-registry/NCT04821960.

International registered report identifier (irrid): PRR1-10.2196/30514.

Keywords: behavioral activation; dementia; fear; memory loss; mindfulness; older adults.

Conflict of interest statement

Conflicts of Interest: None declared.

©Patricia O'Loughlin, Pavithra Pavithra, John Regan, Marc Bennett, Rachel Knight, Bert Lenaert, Melissa Marquez, Michelle Taddeo, James Griffith, Rita Shapiro, Francesca Farina. Originally published in JMIR Research Protocols (https://www.researchprotocols.org), 30.07.2021.

References

    1. Kessler E, Bowen CE, Baer M, Froelich L, Wahl H. Dementia worry: a psychological examination of an unexplored phenomenon. Eur J Ageing. 2012 Sep 22;9(4):275–284. doi: 10.1007/s10433-012-0242-8.
    1. Cutler SJ, Hodgson LG. Anticipatory Dementia: A Link Between Memory Appraisals and Concerns About Developing Alzheimer's Disease. The Gerontologist. 1996 Oct 01;36(5):657–664. doi: 10.1093/geront/36.5.657.
    1. Farina FR, Bennett M, Griffith JW, Lenaert B. Fear of memory loss predicts increased memory failures and lower quality of life in older adults: preliminary findings from a fear-avoidance of memory loss (FAM) scale. Aging & Mental Health. 2020 Dec 09;:1–7. doi: 10.1080/13607863.2020.1856780.
    1. Cheston R, Christopher G. Dementia in Context. Confronting the Existential Threat of Dementia. Berlin, Germany: Springer; 2019. pp. 7–25.
    1. Livingston G, Huntley J, Sommerlad A, Ames D, Ballard C, Banerjee S, Brayne C, Burns A, Cohen-Mansfield J, Cooper C, Costafreda SG, Dias A, Fox N, Gitlin LN, Howard R, Kales HC, Kivimäki M, Larson EB, Ogunniyi A, Orgeta V, Ritchie K, Rockwood K, Sampson EL, Samus Q, Schneider LS, Selbæk G, Teri L, Mukadam N. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. The Lancet. 2020 Aug;396(10248):413–446. doi: 10.1016/s0140-6736(20)30367-6.
    1. Kinzer A, Suhr JA. Dementia worry and its relationship to dementia exposure, psychological factors, and subjective memory concerns. Applied Neuropsychology: Adult. 2015 Oct 23;23(3):196–204. doi: 10.1080/23279095.2015.1030669.
    1. Cutler SJ, Brăgaru C. Long-term and short-term predictors of worries about getting Alzheimer’s disease. Eur J Ageing. 2015 Jul 17;12(4):341–351. doi: 10.1007/s10433-015-0350-3.
    1. Kim S, Werner P, Richardson A, Anstey KJ. Dementia Stigma Reduction (DESeRvE): Study protocol for a randomized controlled trial of an online intervention program to reduce dementia-related public stigma. Contemporary Clinical Trials Communications. 2019 Jun;14:100351. doi: 10.1016/j.conctc.2019.100351.
    1. McWhirter L, Ritchie C, Stone J, Carson A. Functional cognitive disorders: a systematic review. The Lancet Psychiatry. 2020 Feb;7(2):191–207. doi: 10.1016/s2215-0366(19)30405-5.
    1. Stern Y. Cognitive reserve in ageing and Alzheimer's disease. The Lancet Neurology. 2012 Nov;11(11):1006–1012. doi: 10.1016/S1474-4422(12)70191-6.
    1. Grossman P, Kappos L, Gensicke H, D'Souza M, Mohr DC, Penner IK, Steiner C. MS quality of life, depression, and fatigue improve after mindfulness training: A randomized trial. Neurology. 2010 Sep 27;75(13):1141–1149. doi: 10.1212/wnl.0b013e3181f4d80d.
    1. Majeed MH, Ali AA, Sudak DM. Mindfulness-based interventions for chronic pain: Evidence and applications. Asian Journal of Psychiatry. 2018 Feb;32:79–83. doi: 10.1016/j.ajp.2017.11.025.
    1. Nijs J, Roussel N, Paul van Wilgen C, Köke A, Smeets R. Thinking beyond muscles and joints: therapists' and patients' attitudes and beliefs regarding chronic musculoskeletal pain are key to applying effective treatment. Man Ther. 2013 Apr;18(2):96–102. doi: 10.1016/j.math.2012.11.001.
    1. Velthuis MJ, Van den Bussche E, May AM, Gijsen BCM, Nijs S, Vlaeyen JWS. Fear of movement in cancer survivors: validation of the Modified Tampa Scale of Kinesiophobia-Fatigue. Psycho-Oncology. 2011 May 02;21(7):762–770. doi: 10.1002/pon.1971.
    1. Zale EL, Lange KL, Fields SA, Ditre JW. The Relation Between Pain-Related Fear and Disability: A Meta-Analysis. The Journal of Pain. 2013 Oct;14(10):1019–1030. doi: 10.1016/j.jpain.2013.05.005.
    1. Antony M, Barlow D. Handbook of Assessment and Treatment Planning for Psychological Disorders, Third Edition. New York, NY: Guilford Publications; 2020.
    1. Barlow D. Clinical handbook of psychological disorders: A step-by-step treatment manual, 5th edition. New York, NY: The Guilford Press; 2014. p. 978.
    1. Faul F, Erdfelder E, Lang A, Buchner A. G*Power 3: A flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behavior Research Methods. 2007 May;39(2):175–191. doi: 10.3758/BF03193146.
    1. Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O'Neal L, McLeod L, Delacqua G, Delacqua F, Kirby J, Duda SN. The REDCap consortium: Building an international community of software platform partners. Journal of Biomedical Informatics. 2019 Jul;95:103208. doi: 10.1016/j.jbi.2019.103208.
    1. French SL, Floyd M, Wilkins S, Osato S. The Fear of Alzheimer's Disease Scale: a new measure designed to assess anticipatory dementia in older adults. Int J Geriatr Psychiatry. 2011 Jul 01;27(5):521–528. doi: 10.1002/gps.2747.
    1. Carriere JS, Cheyne JA, Smilek D. Everyday attention lapses and memory failures: The affective consequences of mindlessness. Consciousness and Cognition. 2008 Sep;17(3):835–847. doi: 10.1016/j.concog.2007.04.008.
    1. Vinkers DJ, Gussekloo J, Stek ML, Westendorp RGJ, van der Mast RC. The 15-item Geriatric Depression Scale(GDS-15) detects changes in depressive symptoms after a major negative life event. The Leiden 85-plus Study. Int. J. Geriat. Psychiatry. 2004 Jan 5;19(1):80–84. doi: 10.1002/gps.1043.
    1. Silva WAD, de Sampaio Brito TR, Pereira CR. COVID-19 anxiety scale (CAS): Development and psychometric properties. Curr Psychol. 2020 Nov 13;:1–10. doi: 10.1007/s12144-020-01195-0.
    1. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. The Lancet. 2007 Oct;370(9596):1453–1457. doi: 10.1016/S0140-6736(07)61602-X.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren